## IBM: International Business Machines Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%); PEG 2.08 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($278.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. IBM stock drops 1.6% as Big Blue touts Quantum Nighthawk chip ahead of Jan. 28 earnings**
- Source: ts2.tech | 20260103T020615 | Somewhat-Bearish | Relevance: 100%
- IBM stock fell 1.59% to $291.50 on Friday, extending a three-session slide, despite the S&P 500 and Dow closing higher. This decline occurred as IBM introduced early-access availability for its Quantum Nighthawk processor and a new "Heron r3" offering. Investors are now looking ahead to the U.S. jobs data on January 9th and IBM's preliminary earnings date on January 28th.

**2. IBM Gains 33% in a Year: Is it Worth Investing in the Stock Now?**
- Source: Finviz | 20260102T091200 | Bullish | Relevance: 100%
- IBM has seen a 33% increase in its stock value over the past year, outperforming peers like Microsoft and Amazon, driven by strong demand for hybrid cloud and AI products. The company is benefiting from its watsonx platform, a focus on quantum computing through collaborations with Cisco, and positive estimate revisions, making it a potentially solid investment. Despite trading below the industry average in price/sales, it's above its mean, with analysts recommending a "Buy" based on its strong fundamentals and growth prospects.

**3. IBM stock slips below $300 heading into 2026 as Wall Street shuts for New Yearâ€™s Day**
- Source: ts2.tech | 20260101T165716 | Somewhat-Bearish | Relevance: 100%
- IBM shares closed below $300 at $296.21, down 1.9%, on the last trading day of 2025, as Wall Street prepared for the New Year's Day closure. This drop below a key psychological level occurred amid broader year-end pressure on technology stocks and thin holiday trading liquidity. Investors are now looking ahead to IBM's fourth-quarter earnings report and upcoming U.S. economic data in early 2026.

**4. IBM stock slides nearly 2% in year-end session as profit-taking dents Dow**
- Source: ts2.tech | 20260101T030838 | Somewhat-Bearish | Relevance: 100%
- IBM stock fell by about 1.8% in a year-end session, trading around $296.64, as profit-taking and thin liquidity impacted the Dow. An amended SEC filing corrected a prior insider disclosure, though it is not seen as a driver of price action. Investors are now looking ahead to IBM's fourth-quarter earnings report on January 28, 2026.

**5. International Business Machines (NYSE:IBM) Rating Increased to Buy at Wall Street Zen**
- Source: MarketBeat | 20260103T062744 | Bullish | Relevance: 100%
- Wall Street Zen has upgraded International Business Machines (NYSE:IBM) from a "hold" to a "buy" rating. This upgrade aligns with a consensus "Moderate Buy" rating from other analysts, with an average price target of $293.38. IBM recently surpassed quarterly estimates, reporting $2.65 EPS against expectations of $2.45, and revenue of $16.33 billion.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Stifel | $325 | $295 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Stifel | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+0.8%)
- Blackrock Inc.: 8.2% (-1.1%)
- State Street Corpora: 5.8% (-0.1%)
- JPMORGAN CHASE & CO: 3.6% (+49.8%)
- Geode Capital Manage: 2.4% (+1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.08 elevated, pricing in significant growth expectations. Forward P/E 23.9x stretched relative to 7% growth. Quality metrics strong (ROE 30%). Balance sheet: $2.5B free cash flow. Analyst sentiment positive (1 raises, avg +10%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $272.5B |
| Beta | 0.69 |
| 52W Range | $214.50 - $324.90 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.08 |
| Forward P/E | 23.9 |
| Current P/E | 25.7 |
| YoY Growth | 7.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -1.1% to -2.6% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-1.55), momentum weakening. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.62% (CS: 10) | Weak |
| RSI_14 | 34.3 | Neutral |
| MACD Histogram | -1.55 | Bearish |
| vs SMA20 | 0.956x | Below |
| vs SMA50 | 0.959x | Below |
| vs SMA200 | 1.071x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $291.50
- **Stop Loss:** $278.84 (4.3% risk)
- **Target:** $304.16 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 94
- **Position Value:** $27,401.00
- **Portfolio %:** 27.40%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $4.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.45 | $2.65 | +8.3% |
| 2025Q2 | $2.65 | $2.80 | +5.5% |
| 2025Q1 | $1.43 | $1.60 | +12.1% |
| 2024Q4 | $3.78 | $3.92 | +3.8% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*